Quality of life and economic evaluation in SLE clinical trials.
Outcome in SLE patients should include assessment of disease activity and chronic damage and also measurement of health-related quality of life and the economic impact of the disease. This paper reviews the methods available for doing this and the results of existing studies in SLE patients.
Gordon
C
C
Department of Rheumatology, Division of Immunity and Infection, Medical School, University of Birmingham, UK.
Clarke
A E
AE
D001007:Anxiety; D002170:Canada; D002986:Clinical Trials as Topic / Q000379:methods*; D003365:Costs and Cost Analysis; D003863:Depression; D005060:Europe; D005221:Fatigue; D006304:Health Status; D006305:Health Status Indicators; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000191:economics / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D011788:Quality of Life; D011795:Surveys and Questionnaires; D016896:Treatment Outcome